12.12.2018 • NewsHarkeHarke GroupHarke Pharma

Harke and Hulshof joint forces in the sales of beef proteins

Harke FoodTec, a business unit of Harke Pharma and part of the Harke Group in Germany, is now the exclusive distributer of Hulshof Protein Technologies in Europe and Turkey. Harke FoodTec is a specialist in functional ingredients for the meat, fish, poultry, vegetarian and bakery industry and has an European distribution network with own subsidiaries in Belgium, Hungary, Italy, Poland, Romania, Russia, Turkey and United Kingdom. The head office of the Harke Group is in Muelheim an der Ruhr in Germany. Beside the own offices, Harke FoodTec works with sales partners in Belarus, Brazil, Estonia, France, Latvia, Lithuania, Macedonia, The Netherlands, Spain, Switzerland and a recently established cooperation in Mexico.
Hulshof Protein Technologies, part of the Sopraco Group is producing beef protein under the brand name Collapro Bovine in the Netherlands and it is an established company for many years, with excellent meat experts in their organization.

Company

Logo:

Harke Group GmbH

Xantener Str. 1
45479 Mülheim
Germany

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.